Related references
Note: Only part of the references are listed.3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds The ABSORB III Trial
Dean J. Kereiakes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy
Ziad A. Ali et al.
LANCET (2017)
Coronary balloon angioplasty, stents, and scaffolds
Robert A. Byrne et al.
LANCET (2017)
Bioresorbable Scaffolds versus Metallic Stents in Routine PCI
Joanna J. Wykrzykowska et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis A Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort)
Tom Adriaenssens et al.
CIRCULATION (2017)
Drug eluting balloons as stand alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial
Franz X. Kleber et al.
CLINICAL RESEARCH IN CARDIOLOGY (2016)
Randomized Trial of Polymer-Free Sirolimus- and Probucol-Eluting Stents Versus Durable Polymer Zotarolimus-Eluting Stents 5-Year Results of the ISAR-TEST-5 Trial
Sebastian Kufner et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2016)
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial
Patrick W. Serruys et al.
LANCET (2016)
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial
Michael Haude et al.
LANCET (2016)
Five-year outcomes from a trial of three limos-eluting stents with different polymer coatings in patients with coronary artery disease: final results from the ISAR-TEST 4 randomised trial
Sebastian Kufner et al.
EUROINTERVENTION (2016)
Magmaris preliminary recommendation upon commercial launch: a consensus from the expert panel on 14 April 2016
Jean Fajadet et al.
EUROINTERVENTION (2016)
Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary
Robert A. Byrne et al.
EUROPEAN HEART JOURNAL (2015)
Very Late Scaffold Thrombosis Intracoronary Imaging and Histopathological and Spectroscopic Findings
Lorenz Raeber et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents The RIBS IV Randomized Clinical Trial
Fernando Alfonso et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis
George C. M. Siontis et al.
LANCET (2015)
Prognostic role of restenosis in 10 004 patients undergoing routine control angiography after coronary stenting
Salvatore Cassese et al.
EUROPEAN HEART JOURNAL (2015)
2014 ESC/EACTS Guidelines on myocardial revascularization
Stephan Windecker et al.
EUROPEAN HEART JOURNAL (2014)
Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography
Salvatore Cassese et al.
HEART (2014)
Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial
Robert A. Byrne et al.
LANCET (2013)
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial
Michael Haude et al.
LANCET (2013)
Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials
Giulio G. Stefanini et al.
EUROPEAN HEART JOURNAL (2012)
Polymer-Free Sirolimus- and Probucol-Eluting Versus New Generation Zotarolimus-Eluting Stents in Coronary Artery Disease The Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting Versus Zotarolimus-Eluting Stents (ISAR-TEST 5) Trial
Steffen Massberg et al.
CIRCULATION (2011)
Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings
Kumaran Kolandaivelu et al.
CIRCULATION (2011)
Randomized Comparison of a Polymer-Free Sirolimus-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent in Patients With Diabetes Mellitus The LIPSIA Yukon Trial
Steffen Desch et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2011)
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial
Giulio G. Stefanini et al.
LANCET (2011)
ISAR - A Story of Trials With Impact on Practice
Stefanie Schulz et al.
CIRCULATION JOURNAL (2010)
The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts
Kristin Steigerwald et al.
BIOMATERIALS (2009)
Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial
Robert A. Byrne et al.
EUROPEAN HEART JOURNAL (2009)
Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis
Julinda Mehilli et al.
EUROPEAN HEART JOURNAL (2008)
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
Stephan Windecker et al.
LANCET (2008)
Outcomes associated with drug-eluting and bare-metal stents:: a collaborative network meta-analysis
Christoph Stettler et al.
LANCET (2007)
Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents:: a prospective, non-randomised multicentre trial
Raimund Erbel et al.
LANCET (2007)
Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter
Bruno Scheller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk
Michael Joner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
FASTTRACK -: Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymerfree, on-site stent coating
J Hausleiter et al.
EUROPEAN HEART JOURNAL (2005)
Influence of stent surface topography on the outcomes of patients undergoing coronary stenting:: A randomized double-blind controlled trial
A Dibra et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2005)
Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating
R Wessely et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS Stent the TAXUS-IV trial
GW Stone et al.
CIRCULATION (2004)
Inhibition of restenosis in stented porcine coronary arteries - Uptake of paclitaxel from angiographic contrast media
U Speck et al.
INVESTIGATIVE RADIOLOGY (2004)
Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis
B Scheller et al.
CIRCULATION (2004)
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation
B Scheller et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Contrast media as carriers for local drug delivery -: Successful inhibition of neointimal proliferation in the porcine coronary stent model
B Scheller et al.
EUROPEAN HEART JOURNAL (2003)
Intracoronary stenting and angiographic results:: Strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial
J Pache et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
M Morice et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
